Lv4
590 积分 2023-07-13 加入
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11
2天前
已完结
Management Decisions for Metastatic Castration-resistant Prostate Cancer in 2024
8天前
已关闭
DLGAP5 knockdown inactivates the Wnt/β‐catenin signal to repress endometrial cancer cell malignant activities
21天前
已完结
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11
21天前
已完结
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
2个月前
已完结
Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
2个月前
已完结
AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification
6个月前
已完结
TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway
8个月前
已完结
RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway
8个月前
已完结
PLIC11 drives lung cancer progression through regulating the YY1/PIWIL4 axis
9个月前
已完结
皖公网安备34019202002308
